slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,6 CNY | +0,59% |
|
-3,60% | -35,67% |
26/04 | Nanjing Vazyme Biotech Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024 | CI |
15/04 | Chinese aandelen stijgen na nieuwe richtlijnen; HK-aandelen dalen | RE |
Vakgebied
Aantal werknemers: 2 700
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biological Reagent
73,4
%
| 1 437 | 40,3 % | 944 | 73,4 % | -34,33% |
Diagnostic Reagent
19,3
%
| 2 010 | 56,3 % | 248 | 19,3 % | -87,65% |
Technical Services
4,6
%
| 102 | 2,9 % | 60 | 4,6 % | -41,73% |
Diagnostic Instrument
1,6
%
| 16 | 0,4 % | 21 | 1,6 % | +32,00% |
Materials and Other Materials
0,9
%
| - | - | 11 | 0,9 % | - |
Other Business
0,2
%
| 4 | 0,1 % | 2 | 0,2 % | -36,87% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
96,7
%
| 3 335 | 93,6 % | 1 005 | 96,7 % | -69,88% |
Overseas
3,3
%
| 230 | 6,4 % | 34 | 3,3 % | -85,07% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lin Cao
CEO | Chief Executive Officer | 45 | 01-03-12 |
Wen Xin Bi
DFI | Director of Finance/CFO | 48 | 01-09-16 |
Guo Yang Zhang
CHM | Chairman | 35 | 01-07-12 |
Juan Huang
BRD | Director/Board Member | 38 | 01-05-15 |
Li Jun Zhang
BRD | Director/Board Member | 41 | 01-03-12 |
Xiao Mei Hu
BRD | Director/Board Member | 57 | 01-07-17 |
Xi Chen
IRC | Investor Relations Contact | - | - |
Jin Huang
SEC | Corporate Secretary | 33 | 28-05-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kuan Yun Xia
BRD | Director/Board Member | 62 | 28-05-20 |
Jiang Nan Cai
BRD | Director/Board Member | 67 | 28-05-20 |
Lin Cao
CEO | Chief Executive Officer | 45 | 01-03-12 |
Xiao Mei Hu
BRD | Director/Board Member | 57 | 01-07-17 |
Li Jun Zhang
BRD | Director/Board Member | 41 | 01-03-12 |
Bo Tang
BRD | Director/Board Member | 44 | 01-03-20 |
Wei Dong
BRD | Director/Board Member | 60 | 03-09-20 |
Guo Yang Zhang
CHM | Chairman | 35 | 01-07-12 |
Su Feng
BRD | Director/Board Member | 41 | 01-05-17 |
Juan Huang
BRD | Director/Board Member | 38 | 01-05-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 403 021 135 | 83 839 866 ( 20,80 %) | 3 011 135 ( 0,7471 %) | 20,80 % |
Bedrijfsgegevens
Nanjing Vazyme Biotech Co., Ltd.
Building D2 Hongfeng Science Park, Kechuang Road
210033, Nanjing
+
http://www.vazyme.com![Adres Nanjing Vazyme Biotech Co.,Ltd(688105)](https://cdn.zonebourse.com/static/address/147050542.png)
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,67% | 1,13 mld. | |
+51,63% | 796 mld. | |
+41,51% | 628 mld. | |
-5,10% | 358 mld. | |
+19,90% | 331 mld. | |
+9,95% | 301 mld. | |
+17,66% | 244 mld. | |
+3,39% | 228 mld. | |
+10,75% | 214 mld. | |
+6,99% | 165 mld. |
- Beurs
- Aandelen
- Koers 688105
- Onderneming Nanjing Vazyme Biotech Co.,Ltd